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ABSTRACT 42 
Background - Obesity is a multifactorial condition influenced by both genetics and lifestyle. The aim of this study was to 43 
investigate whether the association between a validated genetic profile risk score for obesity (GPRS-obesity) and body 44 
mass index (BMI) or waist circumference (WC) was modified by macronutrient intake in a large general population study.  45 
Methods - This study included cross-sectional data from 48 170 white European adults, aged 37-73 years, participating on 46 
the UK Biobank. Interactions between GPRS-obesity, and macronutrient intake (including total energy, protein, fat, 47 
carbohydrate and dietary fibre intake) and its effects on BMI and WC were investigated.   48 
Results - The 93-SNPs genetic profile risk score was associated with a higher BMI (β:0.57 kg.m-2 per standard deviation 49 
(SD) increase in GPRS, [95%CI:0.53-0.60]; P=1.9x10-183) independent of major confounding factors. There was a 50 
significant interaction between GPRS and total fat intake (P[interaction]=0.007). Among high fat intake individuals, BMI was 51 
higher by 0.60 [0.52, 0.67] kg.m-2 per SD increase in GPRS-obesity; the change in BMI with GPRS was lower among low 52 
fat intake individuals (β:0.50 [0.44, 0.57] kg.m-2). Significant interactions with similar patterns were observed for saturated 53 
fat intake (High β:0.66 [0.59, 0.73] versus Low β:0.49 [0.42, 0.55] kg.m-2, P-interaction=2x10-4), and total energy intake 54 
(High β:0.58 [0.51, 0.64] versus Low β:0.49 [0.42, 0.56] kg.m-2, P-interaction=0.019), but not for protein intake, 55 
carbohydrate intake and fiber intake (P-interaction >0.05). The findings were broadly similar using WC as the outcome.  56 
Conclusions - These data suggest that the benefits of reducing the intake of fats and total energy intake, may be more 57 
important in individuals with high genetic risk for obesity.  58 
Keywords – Obesity, adiposity, genetic risk score, diet, macronutrients  59 
  60 
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INTRODUCTION  61 
The environment in many societies is today considered ‘obesogenic’ suggesting that the dramatic increase in obesity 62 
prevalence over the past three decades has been driven by changes in lifestyle, including increases in energy intake and 63 
reductions in energy expenditure.1, 2 The fact that international obesity prevalence worldwide is not uniform, implies that 64 
there might be gene-environment interactions and that the overall genetic risk is modulated by lifestyle/environment.3, 4 65 
Some genetic factors may operate independently of environment, but others may confer greater predisposition to weight 66 
gain in an obesogenic environment,5 a hypothesis supported by the results of twin studies of changes in adiposity in 67 
response to environmental influences.6, 7 68 
Thus far, limited evidence of genotype-diet interaction effects on adiposity outcomes has been generated, and most of these 69 
studies have been at the single locus level,8-11 despite the genetic influences on BMI being polygenic.12 Furthermore, the 70 
only one study considering GPRS-obesity have used macronutrients to investigate the interaction between diet and GPRS-71 
obesity,13 whereas other 2 studies have used food groups instead of macronutrients.14, 15 To date, no study has investigated 72 
the interaction effect between a GPRS and macronutrient intake on adiposity outcomes. In the current study, therefore, we 73 
investigated whether the associations between GPRS-obesity and adiposity outcomes were modulated by macronutrient 74 
intake (including total energy, protein, fats, carbohydrate, and dietary fibre) in the UK Biobank cohort, a large population 75 
sample. 76 
 77 
METHODS 78 
Study design 79 
This study included cross-sectional baseline data from UK Biobank. Between April 2007 and December 2010, UK Biobank 80 
recruited 502 628 participants (5.5% response rate), aged 37-69 years from the general population.16 Participants attended 81 
one of 22 assessment centres across UK17 where they completed a screening questionnaire (including self-reported dietary 82 
intake), had physical measurements taken and provided biological samples, as described in detail elsewhere.17 Aiming to 83 
maximize homogeneity and GPRS-obesity applicability, we restricted the sample to those who reported being of white UK 84 
ancestry and for whom BMI data were available. Of these participants, 119 859 had genotype data available for the GPRS-85 
obesity SNPs used in this study and 48 170 participants had both dietary intake and genotype data available (Supplemental 86 
Figure 1). 87 
The main outcome measures considered were BMI and waist circumference (WC). The independent predictor variable of 88 
interest was a genetic profile risk score for BMI; macronutrients intake (including total energy, protein, fats, carbohydrate, 89 
and dietary fibre) were treated as effect modifiers. Macronutrient intakes were expressed as age- and sex specific-thirds of 90 
total energy, protein, fat, carbohydrate, and dietary fibre intakes.  91 
Ethics 92 
UK Biobank received ethical approval from the North West Multicenter Research Ethics Committee (reference: 93 
11/NW/03820). All participants gave written, informed consent before enrolment in the study, which was conducted in 94 
accordance with the principles of the Declaration of Helsinki. 95 
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Procedures 96 
Dietary information was collected via the Oxford WebQ; a web-based 24-hour recall questionnaire which was developed 97 
specifically for use in large population studies.18 The Oxford WebQ derives energy intake (total and from specific 98 
macronutrients) from the information recorded in McCance and Widdowson’s “The composition of food. 5th edition”.19 99 
Data for total energy intake is presented as kilocalories per day (kcal.day-1) and protein, carbohydrate and fat intake are 100 
presented as a percentage of total energy (% TE), with dietary fibre presented as grams per day (g.day-1). Subsequently for 101 
analysis purpose these dietary intake variables were converted into tertiles of intakes using the following cut-off points: 102 
Total energy intake (Lower <1845; Middle 1846 to 2319; Higher >2319 kcal.day-1), protein intake (Lower <13.8; Middle 103 
13.8 to 16.5; Higher >16.5 % of TE per day), fat intake (Lower <29.3; Middle 29.3 to 34.8; Higher >34.8 % of TE per day), 104 
saturated fat intake (Lower <10.8; Middle 10.8 to 13.6; Higher >13.6 % of TE per day), carbohydrates (Lower <44.1; 105 
Middle 44.1 to 50.6; Higher >50.6 % of TE per day), and dietary fibre intake (Lower <13.2; Middle 13.2 to 18.3; Higher 106 
>18.3 g.day-1).  107 
Physical activity self-reported PA was recorded using a self-completed questionnaire based on the International Physical 108 
Activity Questionnaire (IPAQ), as described elsewhere.20, 21 Participants were asked "In a typical day, how many hours do 109 
you spend watching TV, doing PC screening or driving?”, and this combined figure was used as a proxy for sedentary 110 
measure.20, 21 Height and body weight were measured by trained nurses and body mass index (BMI) was calculated as 111 
(weight/height2) and the WHO criteria22 used to classify BMI into categories: underweight <18.5, normal weight 18.5-24.9, 112 
overweight 25.0-29.9 and obese ≥30.0 kg.m-2. Central obesity was defined as WC >88 cm for women and >102 cm for 113 
men.22  114 
Area-based socioeconomic status was defined from postcode of residence using the Townsend score.23 Medical history 115 
(physician diagnosis of depression, longstanding illness, diabetes, CVD, and cancer) was collected from baseline 116 
assessment questionnaire. Further details of these measurements can be found in the UK Biobank online protocol 117 
(http://www.ukbiobank.ac.uk). 118 
Genetic data analysis 119 
For the present study, we used the first genetic data release (June 2015) based on approximately one-third of UK Biobank 120 
participants. Approximately 67% of this sample was genotyped using the Affymetrix UK Biobank Axiom array (Santa 121 
Clara, CA, USA) and the remaining 33% were genotyped using the Affymetrix UK BiLEVE Axiom array. The two arrays 122 
share over 95% marker content. Further information on the genotyping process is available on the UK Biobank website 123 
(http://www.ukbiobank.ac.uk/scientists-3/genetic-data), which includes detailed technical documentation 124 
(http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UKBiobank_genotyping_QC_documentation-web.pdf).  125 
We deployed a standard set of sample quality control procedures and excluded participants of a non-white ethnic 126 
background, those with a relatedness coefficient >0.0442, those with a mismatch between self-reported and genetically 127 
determined gender, we also excluded participants who failed quality control for samples and genotype. 128 
GPRS-obesity was derived from a set of 93 SNPs which were in turn derived from the 97 genome-wide significant BMI-129 
associated SNPs reported by Locke et al.12 95 of these 97 SNPs were genotyped in the UK Biobank cohort (the two missing 130 
SNPs were rs2033529 and rs12016871), while two further SNPs (rs9925964 and rs17001654) were excluded on the basis 131 
of deviation from Hardy-Weinberg equilibrium (P <1 x 10-6) as assessed with PLINK v1.90;24 there were no proxy SNPs 132 
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(r>0.8) within the UK Biobank dataset (Supplementary Supplemental Table 1). We constructed an externally-weighted 133 
GPRS-obesity for each participant, weighted by the per allele effect size estimates reported in the GIANT consortium study 134 
(beta per one-SD unit of BMI)12 and calculated according to the procedure given in the PLINK manual 135 
(http://pngu.mgh.harvard.edu/~purcell/plink/profile.shtml), using the -no-mean-imputation flag. All SNPS included in the 136 
GPRS-obesity were significantly associated with BMI.  137 
Statistical analysis 138 
Baseline phenotypic and morbidity data were used for the present analyses. Linear robust regression analysis were used to 139 
test for associations between the main outcomes (BMI and WC) and GPRS-obesity. The GPRS was transformed to a z-140 
score before use in models, so data are presented as BMI or WC changes per SD increase in GPRS. Associations between 141 
GPRS and BMI/WC categories (overweight: BMI ≥25 – 29.9 kg.m-2; obese: BMI ≥30 kg.m-2; centrally-obese: WC ≥88 cm 142 
for women and ≥102 cm for men) were investigated using logistic regression, with the ‘normal’ category as the referent.  143 
Interactions between macronutrient intake (including total energy, protein, fat, carbohydrate, and dietary fibre) and GPRS-144 
obesity in their effects on the continuous outcome measures (BMI and WC) were investigated using robust regression 145 
analysis. Whereas the interaction between macronutrient intake and GPRS-obesity for categorical outcomes (obesity and 146 
central obesity) were investigated using logistic regression. For these the interaction terms each macronutrient intake and 147 
GPRS-obesity were fitted treating all factors as continuous variables [BMI=GPRS x Diet + GPRS + Diet + covariates]. 148 
Continuous measures of macronutrients were used to limit spurious results from gene x environment interactions.  Where 149 
interactions were statistically significant, stratified analyses were undertaken for each exposure.  150 
For each of the approaches described above, we ran two incremental models that included an increasing number of 151 
covariates: “model 0” included age, sex, deprivation index score, month of recruitment, recruitment centre location, 152 
medical history (diabetes, long-standing illness, CVD, cancer, and depression), assessment centre, genetic-related 153 
measurement variables (batch, array number, genetic platform, and 10 principal components axes); “model 1” included all 154 
variables in Model 0, but also adjusted for smoking status, alcohol intake, total physical activity, sedentary behaviours, and 155 
total energy intake (this last one was only included as covariates when not being included in an interaction term).  156 
All analyses were performed using STATA 14 statistical software (StataCorp LP). The P-value threshold for significance 157 
was set at <0.05. 158 
 159 
RESULTS 160 
The main characteristics of the participants by GPRS-obesity quartile, macronutrients intake (including total energy, 161 
protein, fat, carbohydrate and dietary fibre) are summarised in Tables 1 and Supplemental Table 2-7, respectively. In 162 
summary, 53.9% of the cohort was female, mean age was 56.5 years, 8.8% were current smokers, 63.0% were overweight 163 
or obese based on their BMI, and 30.0% were centrally obese based on their waist circumference (WC). Based on self-164 
report total PA, 56.2% of the participants were physically active (>600 MET-min.week-1). Correlations within dietary 165 
variables are presented in Supplemental Table 8; Correlations between obesity markers (BMI and WC) and GPRS-obesity 166 
and macronutrient are presented in Supplemental Table 9. In summary, no significant correlations were found between 167 
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macronutrients and GPRS-obesity, however, BMI and WC were significantly correlated with all macronutrients, these 168 
correlations varied from -0.087 for carbohydrates to 0.127 for total energy intake (Supplemental Table 9).  169 
Association of genetic profile risk score with obesity measures 170 
GPRS-obesity explained 1.9% and 1.1% of the variance in BMI and WC, respectively, with greater genetic risk being 171 
associated, as expected, with a higher BMI [β: 0.60 kg.m-2 increase per SD change in GPRS (95%CI: 0.55, 0.64), p=8x10-172 
189] and greater waist circumference [β: 1.25 cm per SD change in GPRS (95%CI: 1.15, 1.36), p=1.3x10-129]. After 173 
adjustment for socio-demographics, medical history, total sedentary behaviour and dietary factors these associations were 174 
marginally attenuated but remained highly significant for both BMI [β: 0.57 kg.m-2 (95%CI: 0.53, 0.60), p=1.9x10-183] and 175 
waist circumference [β: 1.17 cm (95%CI: 1.07, 1.27), p=6.0x10-125] (Supplemental Table 10 and 11). The odds of having a 176 
BMI ≥25, BMI ≥30, or being centrally obese are presented in supplementary Supplemental Table 10 and 11, and are 177 
broadly consistent: those with increased genetic risk were at increased risk of being overweight or obese in every model.   178 
Interactions between genetic profile risk score and macronutrient intake 179 
The effect of the GPRS-obesity on adiposity was modified by these macronutrients (Figures 1, 2, and Tables 2, 3). The 180 
strongest interaction effect between diet and GPRS was observed for saturated fat intake (P-interaction=2.2x10-4) 181 
independent of main confounder factors (Tables 2 and 3). For the fully adjusted model, the strength of the GPRS 182 
association with the outcomes increased with increasing saturated fat intake: from 0.45 [95% CI: 0.38, 0.51] kg.m-2 per 1 183 
SD increase in the GPRS in participants with the lowest third of intake to 0.65 [0.59, 0.72] kg.m-2 in participants with the 184 
highest third of saturated fat intake (Table 2 and Figure 1). Those in the lowest saturated fat intake third and who were in 185 
the highest quarter of the GPRS-obesity had 1.1 units higher BMI than the lowest quarter of the GPRS-obesity individuals. 186 
However, the individuals with the highest saturated fat intake and in the highest GPRS quarter had 1.8 units higher BMI 187 
compared to the lowest quarter of the GPRS-obesity individuals with the same levels of saturated fat intake (Figure 1). 188 
Similarly, a strong interaction was found for total energy (P-interaction=0.007) and total fat (P-interaction=0.007) but not 189 
carbohydrate, protein and dietary fiber intake (P-interaction >0.05), which significantly modified the effect of the GPRS-190 
obesity on BMI independent of main confounder factors (Table 2 and Figure 1). Comparable findings were found for waist 191 
circumference (Table 3 and Figure 2), although the interaction between GPRS-obesity and total energy intake on WC was 192 
borderline significant (P-interaction =0.016). 193 
Sensitivity analyses were conducted to elucidate whether the interaction between total fat or saturated fat intake and the 194 
GPRS-obesity was independent of total energy intake, and vice versa. These sensitivity analyses did not alter the 195 
interaction and magnitude of the association of our findings (Data not shown).  196 
In addition, we investigated whether the association between GPRS-obesity and overall obesity (BMI >30.0) or waist 197 
circumference cut-offs  (WC ≥88 and ≥102 cm for women and men) were modified by nutrient intake. These results 198 
revealed no significant interactions for any outcomes (Supplemental Table 12 and 13).     199 
 200 
DISCUSSION 201 
Main findings 202 
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This study provides novel evidence that the associations between a 93 SNP genetic profile risk score for obesity and 203 
phenotypic measures of adiposity (BMI and WC) may be substantially modulated by total fat, total energy intake, and in 204 
particular saturated fat. These results extend the limited evidence available to date on the interaction between GPRS-205 
obesity and diet. Moreover, our data indicate that these interactions are likely independent of a range of confounders 206 
including socio-demographic factors, diet, and co-morbidities. These findings emphasise that, although obesity is partly 207 
genetically determined, diet plays an important role in mediating this relationship. Participants with the highest genetic 208 
predisposition to obesity (Quartile 4) who have a high level of saturated fat intake had 1.8 kg.m-2 higher BMI and 3.7 cm 209 
higher WC compare to those with the lowest saturated fat intake but same genetic predisposition; Thus individuals who are 210 
unfortunate enough to be genetically predisposed to obesity can potentially reduce their adiposity by maintaining a lower 211 
level of saturated fat, total fat and therefore total energy intake. Thus, identifying this sub-group of genetically prone (and 212 
thus susceptible) individuals, offering personalised dietary advice and supporting their adoption of a healthier lifestyle, 213 
perhaps particular in following a low fat diet, may be of potential value for personalised health advice. 214 
 215 
It has previously been shown that diet can modulate the effect of genes on obesity traits; however, most of this evidence has 216 
been generated from single genes studies,8, 10, 11 with only a few studies investigating the effect of macronutrients13 or 217 
foods14, 15 on GPRS-obesity. Rukh et al., is the only study to date that have investigated the interaction effect between a 13-218 
SNP genetic risk score and macronutrients on BMI among 26 107 nondiabetic participants.13 This study did not found any 219 
significant interaction between GPRS and dietary intakes of fat, carbohydrates, protein, fibre and total energy intake on 220 
BMI or risk of obesity. These findings are in disagreement with results from the current study, as we provided novel 221 
evidence on the interaction of fats and energy intake with GPRS-obesity on BMI and WC, in a large cohort of white 222 
European adults, and strengthened the limited evidence that genetic predisposition to obesity can be modulated by lifestyle 223 
factors, such as diet8, 10, 14, 15 and physical activity.25 Differences within Rukh et al., and our study could be explained by 224 
difference in the number of SNP used to construct the genetic risk score. Additionally, our study included a larger sample 225 
and used a weighted GPRS-obesity whereas Rukh et al, reported their finding based on an unweighted genetic risk score, 226 
which may not capture difference on the magnitude of association within each SNP and the outcome.  227 
An interesting observation from our study was that the magnitude of the interaction with GPRS-obesity and adiposity was 228 
stronger for saturated fat intake compared to other macronutrients (1.8 kg.m-2 difference in BMI between low and high 229 
GPRS-obesity for a high intake of saturated fat vs 1.1 kg.m-2 difference for a low saturated fat intake). Moreover, this 230 
association was apparently independent of total energy intake. This greater magnitude of the association is in line with 231 
recent finding from the UK Biobank, that suggest that fat makes a greater contribution to overall energy intake than other 232 
macronutrients in all BMI categories, but especially in the obese group.26 Fat intake, especially saturated fat is consider a 233 
surrogate of unhealthy food intake, including processed and other high energy density foods.27, 28 There is ample research 234 
from animal and clinical studies, from controlled trials, and from epidemiologic and ecologic analyses that provides strong 235 
evidence that dietary fat plays a role in the development and treatment of obesity.27, 28 A reduction in fat and total energy 236 
intake will help to maintain energy balance and thus is an effective strategy for reducing the present epidemic of obesity 237 
worldwide.27, 28 A review of the results from 33 randomized controlled trials that studied the effects of a reduction in the 238 
amount of energy from fat in the diet provided high quality and consistent evidence that lower total fat intake leads to 239 
statistically significant and clinically meaningful, sustained reductions in body weight in adults.28 Our results suggest that 240 
individuals with high genetic risk for obesity could moderate the effect of their “bad genes or obesity genes” by reducing 241 
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their total energy intake. This goal can be facilitated by reducing the amount of fats in the diet.  Indeed, our results predict 242 
that such individuals would do better on low fat versus low carbohydrate diets, a testable hypothesis in future trials.  243 
 244 
Strengths and limitations of the study 245 
UK Biobank provided an opportunity to test our research question in a very large general population cohort and the main 246 
outcomes used in this study were collected using validated and standardised methods. Additionally, dietary intake was 247 
assessed using validated methods, trained staff and standard operating procedures.17 Although those who reported 248 
unfeasible energy intake values were removed from the analysis we cannot discard the potential dilution bias due to the 249 
self-reported nature of the dietary data, which could distort the true underlying relationships between diet and our genetic 250 
profile and its effect on adiposity. Another limitation of the study is that the GPRS only captures a small proportion of the 251 
genetic variance in BMI. A polygenic risk score (PRS) analysis may provide greater accuracy in the measurement of the 252 
interaction effects reported here, although it is likely that this will have to await even larger GWAS studies to ensure that 253 
only genuine BMI loci are included in the PRS. Nevertheless, significant interaction effects were detected in our analysis 254 
and power was clearly adequate. A further important limitation is the cross-sectional nature of the study. Future prospective 255 
studies on a massive scale will be needed to estimate the effects of dietary interventions in groups with different genetic 256 
liabilities based on GPRS or PRS variables, and such an analysis was beyond the scope of our study.  257 
 258 
Implications of findings 259 
Data from 900 000 adults reported that 5-kg.m-2 increase in BMI was associated with 40% higher risk for CVD mortality.29 260 
Given the high current prevalence of overweight and obesity worldwide,30 it is important to develop strategies to reduce 261 
adiposity in pursuit of improved public health. The present data – with the most comprehensive genetic profile risk score for 262 
obesity available to date – clearly demonstrate that the association of total energy intake, total fat and saturated fat on adiposity 263 
outcomes are strongest in those with a high genetic predisposition to obesity. Our finding suggest that fat and total energy 264 
intake are other factors which need to be consider, alongside socio-demographic,31 sleep,32 physical activity31, 33 and other 265 
dietary intake patterns.11, 13-15, 31 Evidence of such gene–lifestyle interactions may empower and motivate individuals with 266 
high genetic risk for obesity to adopt healthier lifestyle behaviours through knowledge that such behaviour change can be 267 
effective in preventing obesity and, therefore, risk of obesity-related non-communicable diseases.34-36  268 
In conclusion, despite the fact that this 93-SNP genetic profile risk score was robustly associated with BMI and WC, our 269 
results show that lower levels of total fat and saturated fat intake attenuates the strength of the association between genetic 270 
predisposition to obesity with BMI and waist circumference. These findings are potentially relevant for public health and 271 
suggest that promotion of reducing saturated fat intake particularly in those who are genetically susceptible to higher BMI, 272 
could be an important strategy for addressing the current obesity epidemic and disease burden. Future trials would usefully 273 
test such a hypothesis.  274 
 275 
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Figures legends  414 
 415 
Figure 1. Association between BMI and genetic profile risk score by macronutrients strata 416 
Data presented as adjusted means by dietary intake tertile. Models were adjusted for age, sex, CVD, cancer, diabetes, 417 
depression, long standing illness, genetic-related measurement variables (batch, array number, genetic platform, and 10 418 
principal components axes), smoking, deprivation, month of recruitment, alcohol intake, total PA, sedentary behaviour and 419 
total energy intake (only when this last one was not used as an interaction term).  420 
16 
 
 421 
Figure 2. Association between WC and genetic profile risk score by macronutrients strata 422 
Data presented as adjusted means by dietary intake tertile. Models were adjusted for age, sex, CVD, cancer, diabetes, 423 
depression, long standing illness, genetic-related measurement variables (batch, array number, genetic platform, and 10 424 
principal components axes), smoking, deprivation, month of recruitment, alcohol intake, total PA, sedentary behaviour and 425 
total energy intake (only when this last one was not used as an interaction term).  426 
  427 
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Table 1. Cohort characteristic by genetic profile risk score quartiles 428 
 Overall Q1 (Lowest 
GPRS) 
Q2 Q3 Q4 (Highest 
GPRS) 
Socio-demographics      
Total, n 48 170 12 229     12 037 11 863 12 041 
Women, n (%) 25 982 (53.9) 6 615 (54.1) 6 438 (53.5) 6 425 (54.2) 6 504 (54.0) 
Age (years), mean (SD) 56.5 (7.8) 56.5 (7.8) 56.5 (7.8) 56.5 (7.8) 56.6 (7.8) 
Deprivation index, mean (SD) -1.75 (2.8) -1.74 (2.8) -1.76 (2.7) -1.77 (2.7) -1.75 (2.8) 
Deprivation index Tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
17 964 (37.3) 
16 853 (35.0) 
13 290 (27.6) 
 
4 542 (37.2) 
4 310 (35.3) 
3 358 (27.5) 
 
4 468 (37.2) 
4 225 (35.2) 
3 327 (27.7) 
 
4 454 (37.6) 
4 147 (35.0) 
3 251 (27.4) 
 
4 500 (37.4) 
4 171 (34.7) 
3 354 (27.9) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
27 109 (56.4) 
16 728 (34.8) 
4 250 (8.8) 
 
6 968 (57.1) 
4 132 (33.9) 
1 106 (9.1) 
 
6 843 (56.9) 
4 177 (34.8) 
1 000 (8.3) 
 
6 672 (56.3) 
4 160 (35.1) 
1 010 (8.5) 
 
6 626 (55.1) 
4 259 (35.4) 
1 134 (9.4) 
Obesity-related markers      
BMI (kg.m-2), mean (SD) 26.9 (4.5) 26.2 (4.1) 26.7 (4.4) 27.1 (4.5) 27.7 (4.9) 
BMI Categories, n (%) 
   Underweight (<18.5 kg.m-2) 
   Normal weight (18.5-24.9 kg.m-2) 
   Overweight (25.0-29.9 kg.m-2) 
   Obese (≥30.0 kg.m-2) 
 
259 (0.5) 
17 586 (36.5) 
20 353 (42.3)    9 
972 (20.7) 
 
92 (0.8) 
5 184 (42.4) 
5 047 (41.3) 
1 906 (15.6) 
 
67 (0.6) 
4 588 (38.1) 
5 035 (41.8)2 347 
(19.5) 
 
44 (0.4) 
4 128 (34.8) 
5 170 (43.6) 
2 521 (21.3) 
 
56 (0.5) 
3 686 (30.6) 
5 101 (42.4) 
3 198 (26.6) 
Body fat (%), mean (SD) 30.8 (8.5) 30.0 (8.2) 30.5 (8.4) 30.9 (8.5) 31.7 (8.6) 
Waist Circumference (cm), mean (SD) 89.2 (13.0) 87.6 (12.5) 88.9 (12.8) 89.4 (13.0) 91.0 (13.6) 
Central Obesity, n (%) 14 443 (30.0) 3 060 (25.0) 3 487 (29.0) 3 636 (30.7) 4 260 (35.4) 
Physical activity      
Total PA (METs.hr-1.week-1), mean (SD) 41.9 (53.7) 41.9 (53.4) 41.5 (53.2) 41.9 (53.4) 42.1 (54.6) 
Physically active individuals, n (%) 27 046 (56.2) 6 844 (56.0) 6 811 (56.6) 6 641 (56.0) 6 750 (56.1) 
TV viewing (h.day-1), mean (SD) 2.58 (1.5) 2.54 (1.5) 2.57 (1.5) 2.59 (1.5) 2.63 (1.6) 
Total Sedentary Behaviour (h.day-1), mean 
(SD) 
5.08 (2.2) 5.02 (2.2) 5.07 (2.2) 5.10 (2.2) 5.14 (2.2) 
Dietary intake, mean (SD)      
Total energy intake (Kcal.day-1) 2 171 (563) 2 175 (566) 2 174 (564) 2 172 (561) 2 164.3 (563) 
Protein intake (% of TE) 15.5 (3.4) 15.4 (3.5) 15.3 (3.4) 15.5 (3.4) 15.6 (3.5) 
Carbohydrates intake (% of TE) 46.9 (7.9) 47.0 (7.8) 47.0 (7.9) 47.0 (7.9) 46.8 (8.1) 
Total Fat intake (% of TE) 32.2 (6.6) 32.2 (6.5) 32.2 (6.6) 32.2 (6.5) 32.2 (6.7) 
Saturated intake (% of TE) 12.4 (3.3) 12.4 (3.3) 12.4 (3.3) 12.4 (3.3) 12.4 (3.3) 
18 
 
Dietary fibre intake (g.day-1) 16.4 (6.2) 16.3 (6.1) 16.4 (6.2) 16.4 (6.2) 16.5 (6.3) 
Health status, n (%)      
Diabetes history 1 959 (4.1) 453 (3.7) 447 (3.7) 468 (4.0) 591 (4.9) 
Cancer history 3 651 (7.6) 942 (7.7) 941 (7.8) 858 (7.3) 910 (7.6) 
CVDs 12 956 (26.9) 3 064 (25.1) 3 225 (26.8) 3 236 (27.3) 3 431 (28.5) 
Depression 16 143 (33.7) 4 109 (33.8) 3 938 (32.9) 3 955 (33.5) 4 141 (34.5) 
Long standing illness 14 310 (30.2) 3 499 (29.1) 3 540 (29.9) 3 538 (30.4) 3 733 (31.6) 
Data presented as mean and SD for continuous variables and as n and % for categorical variables. TE: total energy intake. Central obesity was defined as a waist 429 
circumference >88 cm for women and >102 cm for men. Deprivation was derived using the Townsend score (a greater Townsend index score implies a greater degree of 430 
deprivation). Range for the GPRS-obesity are as follow Q1: -4.06 to -0.67 SD; Q2: -0.68 to -0.001 SD; -0.002 to 0.67 SD; Q4: 0.67 to 4.03 SD.  431 
  432 
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Table 2. Association between Genetic Profile Risk Score (GPRS) and BMI by tertile of each macronutrient 433 
  Lower intake Middle intake Higher intake Interaction 
 n B (95% CI) p-value B (95% CI) p-value B (95% CI) p-value p-value 
Total energy intake 
(Kcal.day-1) 
        
Model 0 48 170 0.49 (0.42; 0.56) 3.4x10-46 0.58 (0.51; 0.64) 3.9x10-68 0.58 (0.51; 0.64) 1.9x10-62 0.019 
Model 1 47 608 0.47 (0.41; 0.54) 7.4x10-45 0.54 (0.48; 0.60) 2.7x10-63 0.56 (0.50; 0.63) 2.1x10-64 0.007 
Protein intake  
(% of TE) 
        
Model 0 48 170 0.51 (0.44; 0.58) 8.4x10-52 0.54 (0.47; 0.60) 7.6x10-59 0.58 (0.52; 0.65) 1.1x10-61 0.173 
Model 1 47 609 0.50 (0.44; 0.56) 5.7x10-53 0.52 (0.46; 0.58) 2.9x10-58 0.55 (0.48; 0.62) 8.6x10-58 0.439 
;tal fat intake  
(% of TE) 
        
Model 0 48 170 0.50 (0.44; 0.57) 3.6x10-52 0.55 (0.49; 0.61) 1.1x10-62 0.60 (0.52; 0.67) 2.4x10-61 0.024 
Model 1 47 609 0.48 (0.41; 0.54) 1.6x10-49 0.52 (0.46; 0.58) 4.1x10-60 0.58 (0.51; 0.64) 3.8x10-61 0.007 
Saturated fat intake (% 
of TE) 
        
Model 0 48 170 0.49 (0.42; 0.55) 8.0x10-50 0.50 (0.43; 0.56) 4.5x10-52 0.66 (0.59; 0.73) 4.7x10-75 2.2x10-4 
Model 1 47 609 0.45 (0.38; 0.51) 3.5x10-44 0.48 (0.41; 0.54) 1.8x10-50 0.65 (0.59; 0.72) 1.2x10-77 1.3x10-5 
Carbohydrates intake 
(% of TE) 
        
Model 0 48 170 0.58 (0.52; 0.65) 6.0x10-68 0.49 (0.42; 0.56) 5.1x10-47 0.57 (0.50; 0.63) 7.9x10-60 0.575 
Model 1 47 609 0.56 (0.50; 0.63) 2.7x10-67 0.47 (0.40; 0.53) 1.2x10-45 0.54 (0.47; 0.60) 4.8x10-57 0.772 
Dietary fibre intake  
(g.day-1) 
        
Model 0 48 170 0.56 (0.49; 0.62) 3.6x10-59 0.49 (0.43; 0.56) 4.0x10-48 0.61 (0.54; 0.67) 6.5x10-70 0.505 
Model 1 47 609 0.54 (0.47; 0.60) 6.9x10-58 0.47 (0.41; 0.53) 3.5x10-47 0.57 (0.50; 0.63) 5.8x10-66 0.606 
Data presented as beta coefficients (95%CI). The beta coefficient indicates the change in BMI by 1-tertile increase in the genetic profile risk score by the exposure.  434 
Model 0 was adjusted for age, sex, deprivation, CVD, cancer, diabetes, depression, month of recruitment, and genetic-related measurement variables (assessment centre, 435 
batch, array number, etc.).  436 
Model 1 was adjusted for model 0 plus smoking, alcohol intake, total PA and sedentary behaviour. In addition, model 1 was also adjusted for total energy intake when this 437 
was not used as a main interaction factor in the model.  438 
 439 
 440 
  441 
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Table 3. Association between Genetic Profile Risk Score (GPRS) and waist circumference by tertile of each macronutrient 442 
  Lower intake Middle intake Higher intake Interaction 
Tertile n B (95% CI) p-value B (95% CI) p-value B (95% CI) p-value p-value 
Total energy intake 
(Kcal.day-1) 
        
Model 0 47 783 1.09 (0.92; 1.26) 7.4x10-36 1.12 (0.95; 1.27) 2.0x10-40 1.20 (1.02; 1.37) 5.7x10-42 0.042 
Model 1 47 596 1.04 (0.88; 1.21) 1.2x10-34 1.02 (0.86; 1.18) 9.7x10-37 1.17 (1.00; 1.34) 2.9x10-43 0.016 
Protein intake  
(% of TE) 
        
Model 0 47 784 1.04 (0.87; 1.21) 2.3x10-33 1.10 (0.93; 1.26) 1.0x10-38 1.23 (1.05; 1.40) 1.2x10-43 0.095 
Model 1 47 597 1.03 (0.86; 1.19) 2.0x10-34 1.05 (0.89; 1.21) 1.8x10-37 1.14 (0.98; 1.31) 1.8x10-40 0.234 
Total fat intake  
(% of TE) 
        
Model 0 47 784 1.02 (0.85; 1.19) 1.7x10-32 1.12 (0.96; 1.29) 1.6x10-41 1.24 (1.07; 1.42) 2.2x10-43 0.031 
Model 1 47 597 0.96 (0.80; 1.12) 6.9x10-31 1.06 (0.90; 1.22) 3.7x10-39 1.20 (1.03; 1.37) 3.8x10-43 0.009 
Saturated fat intake (% 
of TE) 
        
Model 0 47 784 0.96 (0.79; 1.13) 2.1x10-29 1.06 (0.89; 1.22) 1.0x10-36 1.37 (1.19; 1.55) 1.6x10-52 0.0003 
Model 1 47 597 0.86 (0.70; 1.03) 1.4x10-25 1.01 (0.85; 1.17) 1.7x10-35 1.35 (1.18; 1.52) 5.8x10-54 2.6x10-5 
Carbohydrates intake 
(% of TE) 
        
Model 0 47 784 1.22 (1.05; 1.38) 8.3x10-47 1.04 (0.87; 1.20) 1.6x10-33 1.10 (0.93; 1.27) 2.1x10-35 0.879 
Model 1 47 597 1.19 (1.03; 1.35) 2.8x10-47 0.98 (0.82; 1.15) 2.6x10-32 1.03 (0.86; 1.20) 4.6x10-33 0.525 
Dietary fibre intake  
(g.day-1) 
        
Model 0 47 784 1.14 (0.97; 1.30) 1.1x10-39 0.99 (0.82; 1.16) 2.6x10-31 1.27 (1.10; 1.45) 2.1x10-47 0.414 
Model 1 47 597 1.10 (0.93; 1.26) 6.5x10-39 0.94 (0.78; 1.10) 3.7x10-30 1.18 (1.02; 1.35) 2.4x10-44 0.532 
Data presented as beta coefficients (95%CI). The beta coefficient indicates the change in waist circumference by 1-tertile increase in the genetic profile risk score by the 443 
exposure.  444 
Model 0 was adjusted for age, sex, deprivation, month of recruitment, CVD, cancer, diabetes, depression and genetic-related measurement variables (assessment centre, 445 
batch, array number, etc.).  446 
Model 1 was adjusted for model 0 plus smoking, alcohol intake, total PA and sedentary behaviour. In addition, model 1 was also adjusted for total energy intake when this 447 
was not used as a main interaction factor in the model. 448 
